Freenome FRNM
NASDAQ FRNM
$13.95 -0.14 (-0.99%)
As of: Aug 27, 2026 · 3:59 PM EDT

Freenome (FRNM) Cash from Operations (2025 - 2026)

Freenome (FRNM) posted quarterly Cash from Operations of 129810.0 for Q2 2026, up 12.01% year-over-year from 115891.52 in Q2 2025, and up 56.42% quarter-over-quarter from 297852.0 in Q1 2026.

Freenome (FRNM) Cash from Operations (2025 - 2026) Analysis & Trends

Freenome's Cash from Operations history runs 2 years deep, the most recent figure standing at 129810.0 for Q2 2026.

  • In Q2 2026, Cash from Operations rose 12.01% year-over-year to 129810.0; the TTM figure through Jun 2026 stood at 907040.0 (changed N/A YoY), while the FY2025 annual figure was 864653.0, down 144.51% from the prior year.
  • Cash from Operations for Q2 2026 stood at 129810.0, up from 297852.0 in the prior quarter.
  • The five-year high for Cash from Operations was 129810.0 in Q2 2026, with the low at 312878.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 2.13 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 1.53 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 54.79 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 277.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 558.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 347.16 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 201.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 310.42 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 445.50 Mn
10 Freenome 152.52 Mn 152.52 Mn - -129,810.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -129,810.00
Jun 30, 2026 -129,810.00
Mar 31, 2026 -297,852.00
Mar 31, 2026 -297,852.00
Dec 31, 2025 -312,878.00
Dec 31, 2025 -312,878.00
Sep 30, 2025 -166,500.00
Sep 30, 2025 -166,500.00
Jun 30, 2025 -147,528.00
Jun 30, 2025 -147,528.00
Mar 31, 2025 -237,747.00
Mar 31, 2025 -237,747.00